The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes
Open accessAbstract
Adiponectin exerts renoprotective effects against diabetic nephropathy (DN) by activating the AMP-activated protein kinase (AMPK)/peroxisome proliferative-activated receptor– α (PPAR α ) pathway through adiponectin receptors (AdipoRs). AdipoRon is an orally active synthetic adiponectin receptor agonist. We investigated the expression of AdipoRs and the associated intracellular pathways in 27 patients with type 2 diabetes and examined the effects of AdipoRon on DN development in male C57BLKS/J db/db mice, glomerular endothelial cells (GECs), and podocytes. The extent of glomerulosclerosis and tubulointerstitial fibrosis correlated with renal function deterioration in human kidneys. Expression of AdipoR1, AdipoR2, and Ca 2+ /calmodulin-dependent protein kinase kinase– β (CaMKK β ) and numbers of phosphorylated liver kinase B1 (LKB1)– and AMPK-positive cells significantly decreased in the glomeruli of early stage human DN. AdipoRon treatment restored diabetes-induced renal alterations in db/db mice. AdipoRon exerted renoprotective effects by directly activating intrarenal AdipoR1 and AdipoR2, which increased CaMKK β , phosphorylated Ser 431 LKB1, phosphorylated Thr 172 AMPK, and PPAR α expression independently of the systemic effects of adiponectin. AdipoRon-induced improvement in diabetes-induced oxidative stress and inhibition of apoptosis in the kidneys ameliorated relevant intracellular pathways associated with lipid accumulation and endothelial dysfunction. In high-glucose–treated human GECs and murine podocytes, AdipoRon increased intracellular Ca 2+ levels that activated a CaMKK β /phosphorylated Ser 431 LKB1/phosphorylated Thr 172 AMPK/PPAR α pathway and downstream signaling, thus decreasing high-glucose–induced oxidative stress and apoptosis and improving endothelial dysfunction. AdipoRon further produced cardioprotective effects through the same pathway demonstrated in the kidney. Our results show that AdipoRon ameliorates GEC and podocyte injury by activating the intracellular Ca 2+ /LKB1-AMPK/PPAR α pathway, suggesting its efficacy for treating type 2 diabetes–associated DN.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AdipoRon has first been proposed for the treatment of type 2 diabetes and other obesity-related disorders in mice [32,106,107,108,137,138].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [32]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Woods, A., Dickerson, K., Heath, R. B., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,418
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Mundel, P. H., Reiser, J., Zúñiga, A., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 876
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Sanders, M. J., Grondin, P., Hegarty, B. D., Snowden, M. A., & Carling, D. (2007) · Biochemical Journal · doi:10.1042/bj20061520 · Cited by 677
Adiponectin regulates albuminuria and podocyte function in mice
Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S., Ouedraogo, R., Hough, K., McCue, P. A., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 609
Lipid Metabolism and Toxicity in the Heart
Goldberg, I. J., Trent, C. M., & Schulze, P. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.006 · Cited by 601
Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., Kamon, J., Kobayashi, M., Suzuki, R., Hara, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402367200 · Cited by 550
Suter, M., Riek, U., Tuerk, R. D., Schlattner, U., Wallimann, T., & Neumann, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606357200 · Cited by 473
Davis, B. J., Xie, Z., Viollet, B., & Zou, M. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1064 · Cited by 465
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 389
Kim, M. Y., Lim, J. H., Youn, H. H., Hong, Y. A., Yang, K. S., Park, H., Chung, S., Koh, S. H., Shin, S. J., Choi, B. S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2747-2 · Cited by 315
Ouedraogo, R., Wu, X., Xu, S., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R. G., & Goldstein, B. J. (2006) · Diabetes · doi:10.2337/db05-1174 · Cited by 256
DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity
Liu, L., Shi, X., Bharadwaj, K. G., Ikeda, S., Yamashita, H., Yagyu, H., Schaffer, J. E., Yu, Y., & Goldberg, I. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049817 · Cited by 245
Screening, Monitoring, and Treatment of Albuminuria
de Jong, P. E., & Curhan, G. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010097 · Cited by 216
Zhou, L., Deepa, S. S., Etzler, J. C., Ryu, J., Mao, X., Fang, Q., Liu, D. D., Torres, J. M., Jia, W., Lechleiter, J. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028357 · Cited by 212
Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 183
Delaney, B., Frazer, S. R., Hess, R., Ostergren, K., Haworth, J., Knutson, N., Nicolosi, R. J., Wilson, T. A., Carlson, T. L., & Zheng, G.-H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.2.468 · Cited by 172
Siddiqi, F. S., & Advani, A. (2013) · Diabetes · doi:10.2337/db13-0795 · Cited by 132
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 121
Handa, P., Maliken, B. D., Nelson, J. E., Morgan‐Stevenson, V., Messner, D. J., Dhillon, B. K., Klintworth, H. M., Beauchamp, M. D., Yeh, M. M., Elfers, C., et al. (2013) · Hepatology · doi:10.1002/hep.26946 · Cited by 95
Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification
Wang, Y., Ma, X. L., & Lau, W. B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.03.004 · Cited by 88
The role of adiponectin in renal physiology and development of albuminuria
Christou, G. A., & Kiortsis, D. N. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0578 · Cited by 86
Ronning After the Adiponectin Receptors
Holland, W. L., & Scherer, P. E. (2013) · Science · doi:10.1126/science.1249077 · Cited by 82
Cha, D. R., Zhang, X., Zhang, Y., Wu, J., Su, D., Han, J., Fang, X., Yu, B., Breyer, M. D., & Guan, Y. (2007) · Diabetes · doi:10.2337/db06-1134 · Cited by 75
Cammisotto, P., Londoño, I., Gingras, D., & Bendayan, M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00373.2007 · Cited by 72
Shin, S. J., Lim, J. H., Chung, S., Youn, D., Chung, H. W., Kim, H. W., Lee, J. H., Chang, Y. S., & Park, C. W. (2009) · Hypertension Research · doi:10.1038/hr.2009.107 · Cited by 63
Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential
Yang, J., Zhang, D., Li, J., Zhang, X., Fan, F., & Guan, Y. (2008) · Clinical Science · doi:10.1042/cs20070462 · Cited by 61
Tamba, S., Nakatsuji, H., Kishida, K., Noguchi, M., Ogawa, T., Okauchi, Y., Nishizawa, H., Imagawa, A., Nakamura, T., Matsuzawa, Y., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.037 · Cited by 49
Adiponectin is expressed and secreted by renal tubular epithelial cells
Perri, A., Vizza, D., Lofaro, D., Gigliotti, P., Leone, F., Brunelli, E., Malivindi, R., Amicis, F. D., Romeo, F., Stefano, R. D., et al. (2013) · Journal of Nephrology · doi:10.5301/jn.5000269 · Cited by 41
Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
Kacsó, I. M., Bondor, C. I., & Kacsó, G. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.668928 · Cited by 34
Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1
Koentges, C., König, A., Pfeil, K., Hölscher, M. E., Schnick, T., Wende, A. R., Schrepper, A., Cimolai, M. C., Kersting, S., Hoffmann, M. M., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0495-4 · Cited by 33
Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy
LI, J., SU, S., & ZONG, X. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1539 · Cited by 22
Changes of adiponectin and its receptors in rats following chronic renal failure
Yu, Y., Bao, B., Fan, Y., Shi, L., & Li, S.-Q. (2013) · Renal Failure · doi:10.3109/0886022x.2013.830975 · Cited by 22
Damned If You Do, Damned If You Don’t: The Conundrum of Adipose Tissue Vascularization
Yilmaz, M., & Hotamışlıgil, G. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.014 · Cited by 17
Cited by
Sorted by citations
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
Fu, Y., Sun, Y., Wang, M., Hou, Y., Huang, W. C., Zhou, D., Wang, Z., Yang, S., Tang, W., Zhen, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.019 · Cited by 220
Tuleta, I., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166044 · Cited by 229
Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction
Nishi, H., Higashihara, T., & Inagi, R. (2019) · Nutrients · doi:10.3390/nu11071664 · Cited by 179
PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases
Lin, Y., Wang, Y., & Li, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074911 · Cited by 166
Metadata
- Authors
- Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Yoon, H. E., Shin, S. J., Choi, B. S., Kim, Y.-S., Chang, Y. S., & Park, C. W.
- Affiliations
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- Corresponding author
- Park, Cheol Whee
- Venue
- Journal of the American Society of Nephrology
- Published
- 2018-01-12
- Volume
- 29
- Issue
- 4
- Pages
- 1108-1127
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5875945
- OpenAlex
- W2783996679
- Cited by
- 229
- References
- 40
- Citations by year
- 2026: 19 · 2025: 31 · 2024: 41 · 2023: 28 · 2022: 30 · 2021: 23 · 2020: 28 · 2019: 22 · 2018: 7
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yonsei University
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- AdipoRon, adiponectin receptor agonist, diabetic nephropathy, type 2 diabetes, AMPK, PPARα, CaMKKβ, LKB1, AdipoR1, AdipoR2, glomerular endothelial cells, podocytes, oxidative stress, apoptosis, endothelial dysfunction, intracellular calcium, cardioprotection, db/db mice
- MeSH terms
- Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Glucose, Humans, Male, Mice, Inbred C57BL, Mice, Obese, Phosphorylation, Piperidines, Protein Processing, Post-Translational, Apoptosis, Protein Serine-Threonine Kinases, Oxidative Stress, Endothelial Cells, PPAR alpha, Podocytes, Mice, Adiponectin, Receptors, Leptin, Receptors, Adiponectin, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
